Instructions to Authors

Contents Page

• How We Publish
• Editorial Policies
• Publication and Research Ethics
• Submission
  • Article Types
  • Preparing Your Manuscript
• Publishing Agreements and Charges

How We Publish

Genomics. Proteomics and Bioinformatics (GPB) is a peer-reviewed fully open access journal publishing 6 issues per year online. All papers published in the Journal are made freely available online under open access publishing agreements, with applicable charges. Please refer to the open access section below.

Once a paper is accepted and the publishing agreement is signed, the Journal will publish the Accepted Manuscript version of the paper (before copyediting and review of the final proof) within one week on the Advance Access page. This will be replaced in Advance Access with the Version of Record of the paper (after copyediting and proof review process) when it is available. The Version of Record will be removed from Advance Access when it is published in an issue. Substantial changes to the published Accepted Manuscript may require a correction notice. The Version of Record requires a correction notice for any changes after it is published, even if it is not yet placed in an issue. See the definitions of the Version of Record and other versions of the paper for more details.

Please read these instructions carefully and follow them closely. The Editors may return manuscripts that do not follow these instructions.

Scope of the Journal

GPB is the official journal of the Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation and Genetics Society of China. The goals of GPB are to disseminate new frontiers in the field of omics and bioinformatics, to publish high-quality discoveries in a fast-pace, and to promote open access and online publication via Article-in-Press for efficient publishing.

GPB is interested in submissions across all areas of life science, biology, and biomedicine, focusing on large data acquisition, analysis, and curation. Manuscripts with topics on omics and the related bioinformatics are all welcome to publish with us.

GPB has been indexed/abstracted by PubMed/MEDLINE, PubMed Central, Scopus, BIOSIS Previews, Chemical Abstracts, CSCD, etc.

GPB's featured research areas include:

• Genomics: large-scale data acquisition, integrated studies and technology developments, concerning genome structures, variations, repeat contents and evolution.
• GPB is interested in submissions across all areas of life science, biology, and biomedicine, focusing on large data acquisition, analysis, and curation. Manuscripts with topics on omics and the related bioinformatics are all welcome to publish with us.
• Other 'omics ' fields: epigenomics (DNA modifications, nucleosome positioning, histone modifications, chromosome conformation and 3-D structures, etc.), ribogenomics (transcriptomics, long-non-coding RNA, antisense transcriptomics, miRNAs, other small RNAs, etc.).
• Proteomics: protein structures, proteomics technology developments, protein expression profiling, protein complexes in terms of structure, function, properties and interactions, metabolomics, homeostasis of macromolecules.
• Bioinformatics: genome assembling, annotation, and integrated analysis; large data curation and mining; sequence-based or matrix-based phylogeny, database construction, web-based platforms and tools, novel algorithms, toolboxes and software packages.

Editorial Policies

Peer Review Process

The Journal operates single-anonymized peer review, meaning that the identity of the authors is known to the editors and to the reviewers, but that the reviewers’ identities are known only to the editors and are hidden from the authors. Once a submitted manuscript passes initial assessment by the Journal’s Editor-in-Chief, it will then be passed to a handling editor to undergo peer review before recommending a final decision. The Editor-in-Chief makes the final decision on the submitted manuscript. During the peer review phase, your manuscript is typically sent to two reviewers. You may suggest potential reviewers at submission. However, there is no guarantee the suggested reviewers will be selected by the Journal. For full details about the peer review process, see Fair editing and peer review or OUP author FAQs.

Appeals and Complaints

Authors may appeal an editorial decision. To do so, please contact the editorial office, providing as much specific detail as possible about why the original decision should be reconsidered. Every appeal will receive a response within a reasonable timeframe. Please do not resubmit your manuscript in the interim. To register a complaint regarding non-editorial decisions, the Journal’s policies and procedures, editors, or staff, please contact us. Complaints will be taken seriously and will be carried forward following COPE guidelines and processes and/or sanctions will be enacted if deemed appropriate.

COVID-19 Rapid Review Initiative

The Journal is participating in the cross-publisher COVID-19 Rapid Review Initiative, facilitating faster peer review for submissions relating to COVID-19. As per the guidelines set forth in the initiative for publishers and editors, COVID-19 related submissions which pass editorial triage will be encouraged to deposit their manuscript in a relevant preprint server. Preprint servers include, but are not limited to bioRxiv, medRxiv, arXiv, OSF Preprints, SciELO Preprints, SSRN, etc., depending on research scope. If you have already posted your manuscript in a preprint server, please state at submission where your manuscript has been deposited. Comments on preprints will be considered during the editorial review process. Because the Journal aims to facilitate the stewardship of FAIR data and software code sharing underlying prioritized COVID-19 manuscripts, a data availability statement is required in these submissions. More information and examples of data availability statements.

Self-archiving

Self-archiving refers to posting a copy of your work on a publicly accessible website or repository. Under certain circumstances, you may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. For information about the Journal's policy, and to learn which version(s) of your paper are acceptable for self-archiving, please see our Author self-archiving policy. 

Availability of Data and Materials

Where ethically feasible, the Journal strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Whenever possible, data should be presented in the main manuscript or additional supporting files or deposited in a public repository. Visit OUP’s Research data page for information on general repositories for all data types, and resources for selecting repositories by subject area. When data and software underlying the research article are available in an online source, authors should include a full citation in their reference list. For details of the minimum information to be included in data and software citations see the OUP guidance on citing research data and software.

Contact Us

For questions regarding submission and review, including appeals, you can reach the editorial office by email at [email protected]. After your paper has been sent to production, you can contact [email protected] for questions regarding the production process or publication. Please see Post-publication changes if you need to request a substantive correction to your published paper.

Publication and Research Ethics

Authorship

Authorship is confined to those who have made a significant contribution to the design and execution of the work described. The Journal will contact all listed authors at the point of submission to confirm their role[AK1] [IW2] . Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. For a detailed definition of authorship, please see the International Committee of Medical Journal Editors (ICMJE) definitions of authors and contributors.

Note: Neither symbolic figures such as Camille Noûs nor natural language processing tools driven by artificial intelligence (AI) such as ChatGPT qualify as authors, and OUP will screen for them in author lists.

The Journal does not allow ghost authorship, where an unnamed author prepares the article with no credit, or guest/gift authorship, where an author who made little or no contribution is listed as an author. The Journal follows Committee on Publication Ethics (COPE) guidance on investigating and resolving these cases. For more information, please see the OUP Publication Ethics page.

After manuscript submission, no authorship changes (including the authorship list, author order, and who is designated as the corresponding author) should be made without the approval of the editor. All co-authors must agree on the change(s), and neither the Journal nor the publisher mediates such disputes. If individuals cannot agree on the authorship of a submitted manuscript, inform the editorial office of the situation. The dispute must be resolved among the individuals and their institution(s) before the manuscript can be accepted for publication. If an authorship dispute or change arises after a paper is accepted, contact OUP’s Author Support team. COPE provides guidance for authors on resolving authorship disputes.

ORCID

All authors are required to provide an ORCID iD (Open Researcher and Contributor ID) at submission. If you do not already have an ORCID iD, you can register for free via the ORCID website. As ORCID identifiers are collected, they are included in papers and displayed online, both in the HTML and PDF versions of the publication, in compliance with recommended practice issued by ORCID. ORCID functionality online allows users to link to the ORCID website to view an author’s profile and list of publications. ORCID iDs are displayed on web pages and are sent downstream to third parties in data feeds, where supported. If you have registered with ORCID, you can associate your ORCID iD with your submission system account by going to your account details, entering your ORCID iD, and validating your details. Learn more about ORCID and how to link it to your account.  

CRediT

The Journal uses the contributor roles taxonomy (CRediT), which allows authors to describe the contributor roles in a standardized, transparent, and accurate way. Authors should choose from the contributor roles outlined on the CRediT website and supply this information upon submission. You may choose multiple contributor roles per author. Any other individuals who do not meet authorship criteria and made less substantive contributions should be listed in your manuscript as non-author contributors with their contributions clearly described. Following manuscript submission, any changes to contributor roles require the approval of the editor.

Disclosure of Potential Conflicts of Interest

Authors

The Journal requires all authors to disclose any potential conflict of interest at the point of submission. Conflicts of interest should be clearly labeled and included at the end of the manuscript. It is the responsibility of the corresponding author to ensure that conflicts of interest of all authors are declared to the Journal. A conflict of interest exists when the position, activities, or relationships of an individual, whether direct or indirect, financial or non-financial, could influence or be seen to influence the opinions or activities of the individual. For more information, refer to OUP’s definition of conflict of interest. The Journal follows the COPE guidance for any undisclosed conflict of interest that emerges during peer review, production, or after publication.

Peer Reviewers

Individuals that have a conflict of interest relating to a submitted manuscript should recuse themselves and will not be assigned to oversee, handle, or peer review the manuscript. If during peer review an editor, reviewer, or author becomes aware of a conflict of interest that was not previously known or disclosed they must inform the Editor-in-Chief immediately.

Editors and Editorial Board Members

At initial submission, the corresponding author must declare if the Editor-in-Chief, an Editor, or an Editorial Board Member of the Journal is an author of or contributor to the manuscript. Another Editor without a conflict of interest will oversee the peer review and decision-making process. If accepted, a statement will be published in the paper describing how the manuscript was handled.

Previously Published Material

You should only submit your manuscript(s) to the Journal if:

• It is original work by you and your co-author(s).
• It is not under consideration, in peer review, or accepted for publication in any other publication.
• It has not been published in any other publication.
• It contains nothing abusive, defamatory, derogatory, obscene, fraudulent, or illegal.

The submitting author must disclose in their cover letter and provide copies of all related or similar preprints, dissertations, manuscripts, published papers, and reports by the same authors (i.e., those containing substantially similar content or using the same, similar, or a subset of data) that have been previously published or posted electronically or are under consideration elsewhere at the time of manuscript submission. You must also provide a concise explanation of how the submitted manuscript differs from these related manuscripts and papers. All related previously published papers should be cited as references and described in the submitted manuscript.

For previously published materials including tables and figures, please see the Reusing copyrighted materials section.

Preprints

As an author, you retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. If accepted, the authors are required to update the status of any preprint, including adding your published paper’s DOI. For full details on allowed channels and updating your preprint, please see our Author self-archiving policy.

Reusing Copyrighted material

As an author, you must obtain permission for any material used within your manuscript for which you are not the rightsholder, including quotations, tables, figures, or images. In seeking permissions for published materials, first contact the publisher rather than the author. For unpublished materials, start by contacting the creator. Copies of each grant of permission should be provided to the editorial office of the Journal. The permissions agreement must include the following:

• nonexclusive rights to reproduce the material in your paper in GPB
• rights for use in print and electronic format at a minimum, and preferably for use in any form or medium
• lifetime rights to use the material
• worldwide English-language rights

If you have chosen to publish under an open access licence but have not obtained open access re-use permissions for third-party material contained within the manuscript, this must be stated clearly by supplying a credit line alongside the material with the following information:

• Title of content
• Author, Original publication, year of original publication, by permission of [rightsholder]
• This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.

Our publisher, Oxford University Press, provides detailed Copyright and Permissions Guidelines, and a summary of the fundamental information.

Misconduct

Authors should observe high standards with respect to research integrity and publication ethics as set out by the Committee on Publication Ethics (COPE). Falsification or fabrication of data including inappropriate image manipulation, plagiarism, including duplicate publication of the author's own work without proper citation, and misappropriation of work are all unacceptable practices.  Allegations of ethical misconduct, both directly and through social media, are treated seriously and will be investigated in accordance with the relevant COPE guidance.

If misconduct has been established beyond reasonable doubt, this may result in one or more of the following outcomes, among others:

• If a submitted manuscript is still under consideration, it may be rejected and returned to the author.
• If a paper has already been published online, depending on the nature and severity of the infraction, either a correction notice will be published and linked to the paper, or retraction of the paper will occur, following the COPE Retraction Guidelines.
• The relevant party’s institution(s) and/or other journals may be informed.

Manuscripts submitted to the Journal may be screened with plagiarism-detection software. Any manuscript may be screened, especially if there is reason to suppose that part or all the of the manuscript has been previously published.

COPE defines plagiarism as “when somebody presents the work of others (data, words or theories) as if they were their own and without proper acknowledgment.”

COPE defines redundant/overlapping publication as “when a published work (or substantial sections from a published work) is/are published more than once (in the same or another language) without adequate acknowledgment of the source/cross-referencing/justification, or when the same (or substantially overlapping) data is presented in more than one publication without adequate cross-referencing/justification, particularly when this is done in such a way that reviewers/readers are unlikely to realise that most or all the findings have been published before.”

COPE defines citation manipulation as “behaviours intended to inflate citation counts for personal gain, such as: excessive self-citation of an authors’ own work, excessive citation to the journal publishing the citing article, and excessive citation between journals in a coordinated manner.”

Data fabrication is defined as intentionally creating fake data or misrepresenting research results. An example includes making up data sets.

Data falsification is defined as manipulating research data with the purpose of intentionally giving a false representation. This can apply to images, research materials, equipment, or processes.

Examples include cropping of gels/images to change context and omission of selected data. If notified of a potential breach of research misconduct or publication ethics, the Journal editor and editorial office staff may inform OUP and/or the author’s institutional affiliation(s).

Ethical Research

The Journal follows Committee on Publication Ethics (COPE) guidelines on ethical oversight.  We take research integrity seriously, and all research published in the Journal must have been conducted in a fair and ethical manner. Wherever appropriate, the Journal requires that all research be done according to international and local guidelines.

Human Subjects

When reporting on human subjects, you should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration, which were developed by the World Medical Association. For non-interventional studies, where ethical approval is not required or where a study has been granted an exemption by an ethics committee, this should be stated within the manuscript with a full explanation. Otherwise, manuscripts must include a statement in the Methods section that the research was performed after approval by a local ethics committee, institutional review board and/or local licensing committee, or that such approval was not required. The name of the authorizing body and any reference/permit numbers (where available) should also be stated there. Please be prepared to provide further information to the editorial office upon request.

Human subjects must give written informed consent, or if they are minors or incapacitated, such consent must be obtained from their parents or guardians. Consent forms should cover not only study participation but also the publication of the data collected. Also, any patient or provider information should be anonymized to the extent possible; names and ID numbers should not be used in the text and must be removed from any images (X-rays, photographs, etc.). Please note blanking out an individual’s eyes in a photograph is not an effective way to conceal their identity. In studies where verbal, rather than written, informed consent was obtained, this must be explained and stated within the manuscript. If informed consent is not required or where a study has been granted an exemption, this must be included in the Methods section along with the name of the authorizing body. Please be prepared to provide written consent forms signed by the participants or other appropriate documentation to the editorial office upon request.

Clinical Trials

Clinical trials should be registered before enrollment of the first subject in accordance with the criteria outlined by the International Committee of Medical Journal Editors (ICMJE). When reporting primary or secondary analyses from a clinical trial, follow these criteria:

• Provide the trial registration number at the end of the Abstract.
• When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference.
• If your data have been deposited in a public repository and/or are being used in a secondary analysis, please state at the end of the Abstract the unique, persistent data set identifier, and repository name and number.
• When submitting the manuscript, you must disclose any protocol alterations and all posting of results of the submitted work or closely related work in registries.

Where available, registration numbers should be provided not only for the trial you are reporting but also for any other trial mentioned in the manuscript. When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference. 

Animal Subjects

Studies involving animals require approval from the relevant institutional ethics committee or institutional animal use and care committee, and the research must be conducted in accordance with applicable national and international guidelines. All such manuscripts must include a statement in the Methods section providing details of the name of the committee(s) that approved the study, as well as the permit or animal licence numbers where available. Where a study has been granted an exemption, this must be stated in the Methods section along with the name of the authorizing body. Please be prepared to provide further information to the editorial office upon request.

ARRIVE Guidelines

You are encouraged to consult the ARRIVE guidelines recommended by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3R).

Euthanasia or Anaesthesia Methods

Where applicable, any euthanasia or anesthesia methods must be carried out in accordance with applicable veterinary guidelines. These methods must be described in detail in the manuscript.

Laboratory Animals

Manuscripts describing research involving laboratory-based animals must include details on housing, husbandry, and steps taken to reduce suffering. In studies where experimental animals were euthanized, details must be provided on humane endpoints. Details on the planned behavioral observations or physiological measurements used to determine the humane endpoint must be described. You are advised to consult the NC3Rs guide on Humane Endpoints and the American Veterinary Medical Association (AVMA) Guidelines for the Humane Slaughter of Animals.

Submission

How to Submit

Authors must submit their papers via our web-based submission system Editorial Manager, which may be found at https://www.editorialmanager.com/gpb/. If authors have not published with GPB before, they will need to create an account. Questions about submitting can be sent to the editorial office at [email protected].

Article Types

This journal publishes several different article types:

Third-Party Permissions

If you wish to reproduce any material for which you do not own the copyright—including quotations, tables, or images—you must obtain permission from the copyright holder. The permissions agreement must include the following documents:

• nonexclusive rights to reproduce the material in your article in Genomics, Proteomics & Bioinformatics
• both print and electronic rights, preferably for use in any form or medium
• lifetime rights to use the material
• worldwide English-language rights

Further information on obtaining permissions is available.

Preparing Your Manuscript

General guidelines on preparing your manuscript for publication can be found on OUP’s Preparing and submitting your manuscript page. Specific instructions for GPB can be found below.

Pre-submission Language Editing

You may wish to use a language-editing service before submitting to ensure that editors and reviewers understand your manuscript. Our publisher, Oxford University Press, partners with Enago, a leading provider of author services. Prospective authors are entitled to a discount of 30% for editing services at Enago, through the OUP-Enago partner page.

Enago is an independent service provider, who will handle all aspects of this service, including payment. As an author you are under no obligation to take up this offer. Language editing is optional and does not guarantee that your manuscript will be accepted. Edited manuscripts will undergo the regular review process of the Journal.

Title Page

Please include the following:

• The title of the paper
• All author names and affiliations
• Mailing address and email address of one corresponding author
• A short running head of [50] characters or less
• 2-6 key words.
• Funding information section
• Acknowledgments section

Abstracts

Text abstracts must be written in English. Abstracts have a maximum length of 200 words and must not contain reference citations or abbreviations.

Acknowledgments

Acknowledgments should be clearly labeled and included at the end of your manuscript and on the title page.

Study Funding

You must fully declare all funding information relevant to the study, including specific grant numbers, under a separate subheading at the end of your manuscript and on the title page.

Abbreviations

Please define nonstandard abbreviations at the first occurrence.

Tables

Authors must number all tables (e.g., table 1, table 2, table 3) and reference them in the text. Authors must place all tables at the end of the main text. Tables should be in an editable format, and not embedded as an image file.

Figures

Figures should be submitted in one of the following file formats: .jpeg, .jpg, .tiff or .eps. Images prepared as .bmp, .gif, .doc/.docx or .pdf files will not be accepted.

You must include figure titles and legends within the manuscript file—they should not be included in the image file.

You must submit each figure as an individual image file. Submit all panels of a multipanel figure on a single page as one file. For example, if the figure has 3 panels, the figure should be submitted as one file. Each panel should be labelled as a letter (A, B, C, D, etc.) in the upper-left corner of each panel.

Images of photographs or paintings can be provided as raster images. The resolution of raster files is measured by the number of dots or pixels in a given area, referred to as “dpi” or “ppi.”

• minimum resolution required for printed images or pictures: 350dpi
• minimum resolution for printed line art: 600dpi (complex or finely drawn line art should be 1200dpi)
• minimum resolution for electronic images (i.e., for on-screen viewing): 72dpi

Images of maps, charts, graphs, and diagrams are best rendered digitally as geometric forms called vector graphics. Vector images use mathematical relationships between points and the lines connecting them to describe an image. These file types do not use pixels; therefore resolution does not apply to vector images.

Figure accessibility and alt text

Incorporating alt text (alternative text) when submitting your paper helps to foster inclusivity and accessibility. Good alt text ensures that individuals with visual impairments or those using screen readers can comprehend the content and context of your figures. The aim of alt text is to provide concise and informative descriptions of your figure so that all readers have access to the same level of information and understanding, and that all can engage with and benefit from the visual elements integral to scholarly content. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is applicable to all images, figures, illustrations, and photographs. 

Alt text is only accessible via e-reader and so it won’t appear as part of the typeset article. 

Detailed guidance on how to draft and submit alt text. 

Reference List

Authors may format references in any readable style at submission. Authors are responsible for the accuracy of reference information. Style files for reference managers are available here.

Supplementary Material

You must submit supplementary data or supplementary material at the same time as the main manuscript.

• Supplementary material must be cited in the text of the main manuscript.
• Supplementary material will be available online only and will not be copyedited or typeset.
• Style and formatting of supplementary material should be consistent with that of the manuscript.
• Supplementary material should be formatted to function on any internet browser.
  • Documentation and online appendices should be submitted in PDF file format.
  • Data files should be submitted in a .zip file format.

Graphical Abstracts

Authors are encouraged to submit a graphical abstract as part of the article, in addition to the text abstract. The graphical abstract should clearly summarize the focus and findings of the article and will be published as part of the article online and in the PDF. The graphical abstract should be submitted for peer review as a separate file, selecting the appropriate file-type designation in the journal’s online submission system. The file should be clearly named, e.g. graphical_abstract.tiff. See this page for guidance on appropriate file format and resolution for graphics.

Alternative name in simplified Chinese

The author can add an alternative name in simplified Chinese together with the English name to appear in both PDF and HTML versions of the article.

The alternative name will not display in search results or indexing services such as PubMed and Web of Science.

This is an optional functionality for GPB Chinese authors. At submission the author should include the simplified Chinese name in parentheses after their primary English name on the manuscript, for example:

Wei Zhang (张伟) and Fang Wang (王芳)

Proofs

The electronic page proofs in PDF format will be delivered to the corresponding author. Corrections should be returned within 48 hours. 'Note added in proof' should only be inserted when there are essential changes. Notes added will be reviewed for appropriate content and style, and are subjected to approval by the editors. Excessive changes, like authors list, affiliations and funding information on the proof should be avoided unless they are for correction of errors introduced during production.

After Publication

Changes to Published Papers

The Journal will only make changes to published papers if the publication record is seriously affected by the academic accuracy of the published information. Changes to a published paper will be accompanied by a formal correction notice linking to and from the original paper. As needed, we follow the COPE guidelines on retractions. For more information and details of how to request changes, including for authors who wish to update their name and/or pronouns, please see OUP’s policy on changes to published papers.

Promoting Your Work

As the author, you are the best advocate for your work, and we encourage you to be involved in promoting your publication. Sharing your ideas and news about your publication with your colleagues and friends could take as little as 15 minutes and will make a real difference in raising the profile of your research.

You can promote your work by:

• Sharing your paper with colleagues and friends. If your paper is published open access, it will always be freely available to all readers, and you can share it without any limitations. Otherwise, use the toll-free link that is emailed to you after publication. It provides permanent, free access to your paper, even if your paper is updated.
• Signing up for an ORCID iD author identifier to distinguish yourself from any other researchers with the same name, create an online profile showcasing all your publications, and increase the visibility of your work.
• Using social media to promote your work. To learn more about self-promotion on social media, see our social media guide for authors.

Find out how Oxford University Press promotes your content.

Publishing Agreements and Charges

Authors, please read each section on the publishing agreement and charges carefully.

Publishing Agreements

After your manuscript is accepted, you will be asked to sign a license to publish through the Journals Licensing and Online Payments portal. The Journal is fully open access, meaning all papers in the Journal are published under an open access license. The corresponding author will need to arrange payment of an open access charge to publish in the Journal. This charge allows all published papers to be immediately and freely available to all readers immediately upon online publication. Editorial decisions occur prior to this step and are not influenced by payment or ability to pay.

Papers can be published under the following:

• Creative Commons Attribution license (CC BY)
• United States Government License
• Crown Copyright License
• Open Government License

Please see the OUP guidance on Licenses, copyright, and re-use rights for more information regarding these publishing agreement options.

Open Government License

The Open Government licence is an open licencing model for content produced by employees of UK Crown bodies allowing users to copy, publish, distribute adapt and transmit the Information for commercial and non-commercial purposes. For additional information see here.

Charges

Open Access Charges

Please see the details of open access licenses and charges. If you select an open access license, you must pay the open access charge or request to use an institutional agreement to pay the open access charge through the Journals Licensing and Online Payments portal.

CC BY licence - $3850 for Protocol, Method, Application Note, Database, Web Server, Original Research, Perspective, Brief Communication, Mini Review, Resource Review, Invited Review and Resources Review.

CC BY licence – $0 for Commentary, Special report, Preface, Historical Note, Research Highlight, Essay, Meeting Report, News and Views, Look Back and Preview.

Waiver Policy

Corresponding authors based in countries and regions that are part of the developing countries initiative receive a full waiver of their open access charge. For further details, please see our open access waiver policy.